These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33954019)

  • 1. Dermoscopic Features as Predictors of
    Filipović N; Šitum M; Buljan M
    Dermatol Pract Concept; 2021 Mar; 11(2):e2021040. PubMed ID: 33954019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between dermoscopic features and BRAF mutational status in cutaneous melanoma: Significance of the blue-white veil.
    Armengot-Carbó M; Nagore E; García-Casado Z; Botella-Estrada R
    J Am Acad Dermatol; 2018 May; 78(5):920-926.e4. PubMed ID: 29307636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between dermoscopic and reflectance confocal microscopy features of cutaneous melanoma with BRAF mutational status.
    Bombonato C; Ribero S; Pozzobon FC; Puig-Butille JA; Badenas C; Carrera C; Malvehy J; Moscarella E; Lallas A; Piana S; Puig S; Argenziano G; Longo C
    J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):643-649. PubMed ID: 27790766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanoma.
    Siroy AE; Aung PP; Torres-Cabala CA; Tetzlaff MT; Nagarajan P; Milton DR; Curry JL; Ivan D; Prieto VG
    Hum Pathol; 2017 Jan; 59():48-54. PubMed ID: 27666765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is BRAF a prognostic factor in stage III skin melanoma? A retrospective study of 72 patients after positive sentinel lymph node dissection.
    Picard M; Pham Dang N; D'Incan M; Mansard S; Dechelotte P; Pereira B; Mondie JM; Barthelemy I
    Br J Dermatol; 2014 Jul; 171(1):108-14. PubMed ID: 24602025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermoscopic similarity is an independent predictor of BRAF mutational concordance in multiple melanomas.
    Moscarella E; Pellegrini C; Pampena R; Argenziano G; Manfredini M; Martorelli C; Ciarrocchi A; Dika E; Peris K; Antonini A; Cipolloni G; Alfano R; Longo C; Fargnoli MC
    Exp Dermatol; 2019 Jul; 28(7):829-835. PubMed ID: 31034104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and dermoscopic criteria related to melanoma sentinel lymph node positivity.
    Pagnanelli G; Bono R; Pizzichetta MA; Talamini R; Ascierto PA; Testori A; Stanganelli I;
    Anticancer Res; 2007; 27(4C):2939-44. PubMed ID: 17695474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermoscopic criteria associated with BRAF and NRAS mutation status in primary cutaneous melanoma.
    Pozzobon FC; Puig-Butillé JA; González-Alvarez T; Carrera C; Aguilera P; Alos L; Badenas C; Grichnik JM; Malvehy J; Puig S
    Br J Dermatol; 2014 Oct; 171(4):754-9. PubMed ID: 24749938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermoscopy structures as predictors of sentinel lymph node positivity in cutaneous melanoma.
    González-Álvarez T; Carrera C; Bennassar A; Vilalta A; Rull R; Alos L; Palou J; Vidal-Sicart S; Malvehy J; Puig S
    Br J Dermatol; 2015; 172(5):1269-77. PubMed ID: 25418318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAF immunohistochemistry predicts sentinel lymph node involvement in intermediate thickness melanomas.
    Manninen AA; Gardberg M; Juteau S; Ilmonen S; Jukonen J; Andersson N; Carpén O
    PLoS One; 2019; 14(4):e0216043. PubMed ID: 31039200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRAF mutation screening in melanoma: is sentinel lymph node reliable?
    Nardin C; Puzenat E; Prétet JL; Algros MP; Doussot A; Puyraveau M; Mougin C; Aubin F
    Melanoma Res; 2015 Aug; 25(4):328-34. PubMed ID: 26020488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermoscopy and confocal microscopy for metachronous multiple melanomas: morphological, clinical, and molecular correlations.
    Colombino M; Paliogiannis P; Pagliarello C; Cossu A; Lissia A; Satta R; Mazzoni L; Magi S; Sini MC; Manca A; Casula M; Doneddu V; Palmieri G; Stanganelli I
    Eur J Dermatol; 2018 Apr; 28(2):149-156. PubMed ID: 29180316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour mutation status and sites of metastasis in patients with cutaneous melanoma.
    Adler NR; Wolfe R; Kelly JW; Haydon A; McArthur GA; McLean CA; Mar VJ
    Br J Cancer; 2017 Sep; 117(7):1026-1035. PubMed ID: 28787433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
    Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
    J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of clinical parameters associated with mutational status in metastatic malignant melanoma: a single-centre investigation of 141 patients.
    Schlaak M; Bajah A; Podewski T; Kreuzberg N; von Bartenwerffer W; Wardelmann E; Merkelbach-Bruse S; Büttner R; Mauch C; Kurschat P
    Br J Dermatol; 2013 Apr; 168(4):708-16. PubMed ID: 23528057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary excision margins, sentinel lymph node biopsy, and completion lymph node dissection in cutaneous melanoma: a clinical practice guideline.
    Wright FC; Souter LH; Kellett S; Easson A; Murray C; Toye J; McCready D; Nessim C; Ghazarian D; Hong NJL; Johnson S; Goldstein DP; Petrella T;
    Curr Oncol; 2019 Aug; 26(4):e541-e550. PubMed ID: 31548823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vertical Growth Phase as a Prognostic Factor for Sentinel Lymph Node Positivity in Thin Melanomas: A Systematic Review and Meta-Analysis.
    Appleton SE; Fadel Z; Williams JS; Bezuhly M
    Plast Reconstr Surg; 2018 Jun; 141(6):1529-1540. PubMed ID: 29579032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care.
    Heppt MV; Siepmann T; Engel J; Schubert-Fritschle G; Eckel R; Mirlach L; Kirchner T; Jung A; Gesierich A; Ruzicka T; Flaig MJ; Berking C
    BMC Cancer; 2017 Aug; 17(1):536. PubMed ID: 28797232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node biopsy for melanoma: experience with 234 consecutive procedures.
    Wagner JD; Corbett L; Park HM; Davidson D; Coleman JJ; Havlik RJ; Hayes JT
    Plast Reconstr Surg; 2000 May; 105(6):1956-66. PubMed ID: 10839392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.